Abstract
Cancer is the result of cumulative multiple genetic mutations, which result in the activation of oncogenes and / or the inactivation of tumor suppressor genes. Current theories of malignant transformation postulate that the development of primary brain tumors is the consequence of the sequential accumulation of multiple genetic alterations in brain cells, each of which contributes to the induction of a progressively more malignant phenotype. Traditionally, our understanding of brain tumor biology has come from the study of single specific genes or chromosome regions at a time. Although several genetic aberrations and gene expression changes have been identified using such focused techniques, the traditional methods of cancer research are tediously slow and provide limited insight into the global gene expression patterns that occur during the malignant transformation, development, and progression of primary brain cancers. Because hundreds of genes may be simultaneously involved in the mechanisms of ca rcinogenesis, new genomic high-throughput technologies have recently come into the forefront of cancer research. These technologies, which include cDNA and oligonucleotide microarrays (gene chips) and tissue microarray (tissue chip) techniques, may considerably facilitate the molecular profiling of human tumors. Such molecular fingerprinting of malignant gliomas, for example, may lead to advances in diagnosis, prognosis, and design of novel therapeutic approaches that could improve the clinical outcome of patients suffering from this rapidly fatal disease. This review will describe the principles of microarray technology as applied to human brain tumor research, summarize its use and limitations in identifying brain tumor-associated genes thus far, and speculate on the future applications and clinical ramifications of such genomic large-scale screening techniques in neuro-oncology.
Keywords: Microarrays, Brain Tumors, cancer, cdna microarrays, tissue microarray tma analysis, insulin-like growth, protein2 1gfbp2, facetor binding gene
Current Genomics
Title: Microarrays and the Genetic Analysis of Brain Tumors
Volume: 3 Issue: 1
Author(s): L. M. Liau and I. Yang
Affiliation:
Keywords: Microarrays, Brain Tumors, cancer, cdna microarrays, tissue microarray tma analysis, insulin-like growth, protein2 1gfbp2, facetor binding gene
Abstract: Cancer is the result of cumulative multiple genetic mutations, which result in the activation of oncogenes and / or the inactivation of tumor suppressor genes. Current theories of malignant transformation postulate that the development of primary brain tumors is the consequence of the sequential accumulation of multiple genetic alterations in brain cells, each of which contributes to the induction of a progressively more malignant phenotype. Traditionally, our understanding of brain tumor biology has come from the study of single specific genes or chromosome regions at a time. Although several genetic aberrations and gene expression changes have been identified using such focused techniques, the traditional methods of cancer research are tediously slow and provide limited insight into the global gene expression patterns that occur during the malignant transformation, development, and progression of primary brain cancers. Because hundreds of genes may be simultaneously involved in the mechanisms of ca rcinogenesis, new genomic high-throughput technologies have recently come into the forefront of cancer research. These technologies, which include cDNA and oligonucleotide microarrays (gene chips) and tissue microarray (tissue chip) techniques, may considerably facilitate the molecular profiling of human tumors. Such molecular fingerprinting of malignant gliomas, for example, may lead to advances in diagnosis, prognosis, and design of novel therapeutic approaches that could improve the clinical outcome of patients suffering from this rapidly fatal disease. This review will describe the principles of microarray technology as applied to human brain tumor research, summarize its use and limitations in identifying brain tumor-associated genes thus far, and speculate on the future applications and clinical ramifications of such genomic large-scale screening techniques in neuro-oncology.
Export Options
About this article
Cite this article as:
Liau M. L. and Yang I., Microarrays and the Genetic Analysis of Brain Tumors, Current Genomics 2002; 3 (1) . https://dx.doi.org/10.2174/1389202023350633
DOI https://dx.doi.org/10.2174/1389202023350633 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Copper Compounds in Anticancer Strategies
Current Medicinal Chemistry Meet Our Associate Editor
Current Bioactive Compounds Polyphenols: Biological Activities, Molecular Targets, and the Effect of Methylation
Current Molecular Pharmacology RNA Splicing: Basic Aspects Underlie Antitumor Targeting
Recent Patents on Anti-Cancer Drug Discovery Salen Mn Complexes Mitigate Radiation Injury in Normal Tissues
Anti-Cancer Agents in Medicinal Chemistry In Silico Prediction Models for Blood-Brain Barrier Permeation
Current Medicinal Chemistry 1-O-Octadecyl-2-O-Methylglycero-3-phosphocholine (Edelfosine) and Cancer Cell Invasion: A Short Review
Anti-Cancer Agents in Medicinal Chemistry Gold Nanoparticle-Based Drug Delivery Platform for Antineoplastic Chemotherapy
Current Drug Metabolism Glycobiology in Malignant Gliomas: Expression and Functions of Galectins and Possible Therapeutic Options
Current Pharmaceutical Biotechnology Diagnosis and Management of Endocrine Hypertension in Children and Adolescents
Current Pharmaceutical Design Small Molecule Inhibitors Targeting Key Proteins in the DNA Damage Response for Cancer Therapy
Current Medicinal Chemistry Effectivity of Long Antigen Exposition Dendritic Cell Therapy (LANEXDC<sup>®</sup>) in the Palliative Treatment of Pancreatic Cancer
Current Medicinal Chemistry New Therapeutic Strategies for Cancer and Neurodegeneration Emerging from Yeast Cell-based Systems
Current Pharmaceutical Design Overexpression of Nemo-like Kinase Promotes the Proliferation and Invasion of Lung Cancer Cells and Indicates Poor Prognosis
Current Cancer Drug Targets Cross Talk between the Cardiovascular and Nervous Systems:Neurotrophic Effects of Vascular Endothelial Growth Factor (VEGF) and Angiogenic Effects of Nerve Growth Factor (NGF)-Implications in Drug Development
Current Pharmaceutical Design PLGA Hollow Microbubbles Loaded with Iron Oxide Nanoparticles and Doxorubicin for Dual-mode US/MR Imaging and Drug Delivery
Current Nanoscience Polyphenols and Neuroprotection against Ischemia and Neurodegeneration
Mini-Reviews in Medicinal Chemistry Research Toward Potassium Channels on Tumor Progression
Current Topics in Medicinal Chemistry Inhibitors of the Hedgehog Signal Transduction Pathway
Current Cancer Therapy Reviews cAMP-Mediated Regulation of CYP Enzymes and Its Application in Chemotherapy
Drug Metabolism Letters